Join to View Full Profile
5150 Centre AveSte 414Pittsburgh, PA 15232
Phone+1 412-623-4861
Fax+1 412-692-2520
Dr. Kammula is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Udai S. Kammula, MD, FACS, is an associate professor and director of the Solid Tumor Cell Therapy Program at UPMC Hillman Cancer Center, and surgical oncologist in the Department of Gastrointestinal Surgical Oncology. His research and clinical expertise includes cancer immunology, adoptive T cell transfer, gene therapy, and tumor-infiltrating lymphocytes.
Board-certified in surgery, Dr. Kammula received his medical degree from the University of Maryland School of Medicine in Baltimore. He completed his general surgery residency at University of Chicago Medical Center, IL, and his surgical oncology and immunotherapy clinical and research fellowship at the National Cancer Institute in Bethesda, MD. He also completed a surgical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2002 - 2004
University of ChicagoResidency, Surgery, 1994 - 2002
University of Maryland School of MedicineClass of 1994
Certifications & Licensure
PA State Medical License 2017 - 2026
NY State Medical License 2002 - 2017
MD State Medical License Active through 2014
IL State Medical License 1996 - 2002
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow American College of Surgeons
Clinical Trials
- Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma Start of enrollment: 2008 Apr 01
- Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma Start of enrollment: 2013 Mar 01
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma Start of enrollment: 2018 May 14
- Join now to see all
Publications & Presentations
PubMed
- The T cell receptor landscape of childhood brain tumors.Itay Raphael, Zujian Xiong, Chaim T Sneiderman, Rebecca A Raphael, Moshe Mash
Science Translational Medicine. 2025-03-19 - Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma.Shravan Leonard-Murali, Udai S Kammula
Immunotherapy. 2025-03-18 - 7 citationsUveal melanoma immunogenomics predict immunotherapy resistance and susceptibility.Shravan Leonard-Murali, Chetana Bhaskarla, Ghanshyam S Yadav, Sudeep K Maurya, Chenna R Galiveti
Nature Communications. 2024-04-16
Press Mentions
Classifying Childhood Brain Cancers by Immune Response May Improve Diagnostics and TreatmentsMarch 19th, 2025- Immunogenomics Is on the Way UpAugust 12th, 2024
- Beckwith Institute Awards Research GrantsJune 30th, 2021
- Join now to see all
Grant Support
- Postdoctoral Research Training in Biotherapy of CancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2006–2029
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
